Tami Wilson-Ciranna, President & CFO

Professional Overview

Tami Wilson-Ciranna is an accomplished finance executive with over 30 years of experience spanning a diverse range of industries. As the President and Chief Financial Officer of Curative Inc., she oversees all aspects of the company's financial operations, strategic planning, and business development initiatives. With a strong background in management consulting, biotechnology, and commercial real estate, Tami brings a unique blend of financial acumen and operational expertise to her leadership role.

Experience Summary

Current Role

As President and CFO of Curative Inc., Tami is responsible for driving the company's financial strategy, optimizing operational efficiency, and supporting the organization's ambitious growth objectives. Under her stewardship, Curative has achieved significant milestones, including securing major funding rounds, expanding its product portfolio, and enhancing its market presence. Tami's strategic vision and collaborative leadership style have been instrumental in positioning Curative as a key player in the healthcare technology sector.

Career Progression

Prior to joining Curative, Tami served as a Consultant, where she provided strategic advisory services to a diverse client base, helping organizations navigate complex financial and operational challenges. She also held the role of Chief Financial Officer at Prolacta Bioscience, Inc., where she played a pivotal role in the company's successful turnaround and expansion. Earlier in her career, Tami held the position of CFO at CommonWealth Partners, a leading commercial real estate firm, and was a Partner at the prestigious accounting firm, Arthur Andersen LLP.

Academic Background

Tami holds a Bachelor of Science degree in Accounting from the University of Texas at Austin, where she graduated with high honors. She is a Certified Public Accountant (CPA) and maintains a strong commitment to continuous learning and professional development.

Areas of Expertise

Tami's areas of expertise include financial management, strategic planning, mergers and acquisitions, operational optimization, and business transformation. She has a proven track record of delivering measurable results, driving operational efficiencies, and fostering collaborative work environments that enable teams to thrive.

Professional Impact

Throughout her illustrious career, Tami has played a pivotal role in the success of several organizations. At Prolacta Bioscience, she led the company's financial turnaround, resulting in a significant improvement in profitability and market share. In her previous role at CommonWealth Partners, Tami oversaw the successful execution of several high-profile real estate transactions, contributing to the firm's reputation as an industry leader.

Conclusion

Tami Wilson-Ciranna is a seasoned finance executive with a proven track record of driving growth, optimizing operations, and delivering sustainable value for the organizations she serves. Her strategic vision, financial acumen, and collaborative leadership style make her a valuable asset to Curative Inc. as the company continues to innovate and expand its footprint in the healthcare technology sector.